Search

everythinglearnresearchcommunity

for

Search:↓

Guselkumab effectively reduces fatigue in Psoriatic Arthritis patients over two years.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Stopping the medication infliximab and starting new treatments helped a woman's hair grow back and improved her scalp condition.

Combining glucocorticoids with immunosuppressants like cyclophosphamide improves remission and reduces relapse in pemphigus patients.

Bimatoprost shows promise for treating vitiligo, especially when combined with other therapies.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

The BIOMAP glossary standardizes data to improve research on atopic dermatitis and psoriasis.

The document corrects a mistake by stating that pimecrolimus, not tacrolimus, is the drug that concentrates in the skin.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.

Rituximab can cause skin issues, but baricitinib may help improve them.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

Mimosine dipeptides are promising for treating hyperpigmentation and inflammation.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Combining mesotherapy with systemic treatments effectively improves alopecia universalis treatment.

Rituximab may cause skin issues, but baricitinib can help improve them.

Membership in a self-help organization is linked to being better informed and having a higher education, but it doesn't clearly affect disease outcomes.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Bimatoprost solution is effective and safe for long-term use in treating eyelash thinning.

BKN-1 antibody targets specific keratin in basal cell epithelioma and normal skin basal cells.

Pemphigus vulgaris involves specific immune cells and B cells that produce antibodies causing skin blisters.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.